trial · primary record
KK2269
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 83 |
| Primary completion | 2029-03 |
| Primary endpoint | Number of Subjects Experiencing Dose-limiting Toxicity |
| Registry ID | NCT06266299 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:52.686Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06266299
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.